1 active trials 0 recruiting 1 Phase 3 1 disease areas
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06680258 | A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or… | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting | 2025-09-03 |
Liver Cancer (1)